Poultry health is becoming a growing concern all over the world owing to increasing disease outbreaks and stringent food safety regulations which will help the Poultry diagnostics market to grow significantly. Avian influenza, Newcastle disease, infectious bronchitis, and mycoplasmosis are just some of the diseases that poultry farms and commercial producers are responding to with cutting-edge diagnostic tools.
With increased industrialization of poultry farming, the priority of disease control has led to an increased demand for real-time PCR testing, ELISA assays, and rapid diagnostic kits.
The market is estimated to grow up to USD 720.40 Million in 2025 and to USD 1,868.4 Million for decade in 2035 with a 10% CAGR during the forecasted period. Technological evolutions in point-of-care diagnostics, biosensors and AI-based disease surveillance systems are also facilitating the market growth.
Market Metrics
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 720.40 Million |
| Market Value (2035F) | USD 1,868.4 Million |
| CAGR (2025 to 2035) | 10% |
Explore FMI!
Book a free demo
North America holds the largest share in the global Poultry Diagnostics Market, with The United States and Canada being key contributors owing to high biosecurity rules, large-scale poultry farm operations, and increased awareness about disease surveillance.
Government agencies, including the USDA and FDA, enforce comprehensive disease control programs that spur the development of early detection and rapid diagnostic technologies. The region also benefits from advancements in molecular diagnostics as well as the presence of major poultry health companies.
Europe accounts for a significant market share, with Germany, the UK, and France leading poultry disease management activities. The European Union prohibited the use of antibiotic growth modifiers in poultry farming, resulting in an increased dependence on preventive health methods and advanced diagnostics. In this region, the market is levelled up by investments in veterinary study and disease surveillance programs.
Asia-Pacific is projected to be the fastest-growing region due to the growing poultry production, increasing demand for animal protein and rising number of outbreaks of disease. China, India, and Indonesia are important markets, as governments are investing in poultry health management and vaccination programs.
The mushrooming industrialization of poultry farming, coupled with increasing awareness and expectation relating to the prevention of disease is significantly driving the uptake of diagnostic solutions.
High Cost of Advanced Diagnostic Technologies
Small and mid-sized poultry farms face challenges in investing to cultivate molecular diagnostics and real-time disease monitoring tools. Furthermore, the unavailability of specialized diagnostic centres in developing areas is reducing the rapid identification of the disease, resulting in economic repercussions in the form of poultry deaths and unproductive egg and meat production.
To overcome these limitations, the different companies are aiming to develop cost-effective rapid test kits and mobile diagnostic solutions for poultry disease detection.
Growth of AI-Powered Disease Surveillance and Portable Diagnostic Devices
Artificial intelligence (AI), machine learning, and IoT-enabled disease monitoring systems are changing the paradigm of poultry diagnostics. By predicting disease outbreaks, analysing flock health data, and sending real-time alerts to farmers, AI-powered platforms enhance disease prevention efforts.
Also, the innovation of portable devices for diagnosis, biosensors, and smartphone approaches for testing are speeding the on-site diagnosis of poultry diseases to be more cost-effective and efficient. Businesses are likely to get a competitive edge in the evolving market by investing in automated real-time diagnostic solutions.
From 2020 to 2024, the poultry diagnostics market grew significantly driven by the high occurrence of potent avian diseases such as avian influenza, Newcastle disease and infectious bronchitis. The growing global trend of increased meat consumption and egg production increased the demand for disease surveillance and biosecurity within the poultry industry.
ELISA (enzyme-linked immunosorbent assay) and PCR (polymerase chain reaction)-based assays were adopted by veterinary laboratories and poultry farms for diagnosis and control of the disease. The need for cost-effective, rapid and point-of-care diagnostics has spurred advances in portable testing devices and lateral flow assays.
These challenges involved high prices of advanced diagnostic tools, limited accessibility in developing areas, and the emergence of antibiotic-resistant pathogens. But some of these challenges were alleviated by federal initiatives, outreach efforts by veterinarians and the investment in research on livestock disease.
From 2025 to 2035, the poultry diagnostics market will experience technological disruption supported by AI-backed disease detection, connected biosensors, and digital health platforms.
Real-time monitoring of poultry health, so that disease outbreaks can be detected before physical manifestations of these diseases can be seen by the naked eye will be possible through the integration of artificial intelligence and machine learning.
With portable biosensors and nanotechnology-based diagnostic kits, highly sensitive detection of viral and bacterial infections will be possible with minimal dependence on centralized laboratories.
Blockchain-empowered disease monitoring solutions and cloud-based veterinary platforms will bring more transparency to the supply chain and better disease prevention measures. By developing CRISPR-based diagnostics, it would provide ultra-rapid early testing at a low cost, facilitating the containment of infectious diseases
Market Shifts: A Comparative Analysis 2020 to 2024 vs. 2025 to 2035
| Market Shift | 2020 to 2024 |
|---|---|
| Disease Surveillance | ELISA and PCR-based testing for avian diseases. |
| Technology Advancements | Development of rapid test kits and portable diagnostic tools. |
| Veterinary and Farm Adoption | Growing use of centralized labs for poultry disease testing. |
| Regulatory and Biosecurity Measures | Strengthening of disease control regulations and vaccination programs. |
| Market Growth Drivers | Rising demand for poultry products and growing concerns over zoonotic diseases. |
| Market Shift | 2025 to 2035 |
|---|---|
| Disease Surveillance | AI-driven predictive diagnostics and smart biosensors for real-time monitoring. |
| Technology Advancements | Adoption of CRISPR-based and nanotechnology-enhanced diagnostic solutions. |
| Veterinary and Farm Adoption | Integration of on-farm digital diagnostics and cloud-based health monitoring. |
| Regulatory and Biosecurity Measures | AI-powered disease forecasting models to enhance preventive strategies. |
| Market Growth Drivers | Expansion of automated veterinary diagnostics and blockchain -enabled disease tracking. |
The poultry diagnostics market in the United States is driven by the rising incidences of avian diseases, including avian influenza and Newcastle disease. Increasing consumption of high-quality poultry products and strict government regulations regarding food safety and disease control are other factors contributing to market growth. Market growth is being propelled by the increasing adoption of advanced diagnostic techniques, such as PCR-based tests and ELISA kits.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 9.8% |
The United Kingdom poultry diagnostics market is influenced by increasing focus on zoonotic diseases and stringent regulations on poultry health monitoring.
The market is gaining from a surge in the use of rapid testing methods as well as advances in veterinary diagnostics. Furthermore, the growing interest in antibiotic-free poultry has led farmers to adopt more precise disease identification strategies.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 9.9% |
The poultry diagnostics market in the European Union is registering significant growth owing to rising consciousness about animal health and biosecurity measures.
The market is also being facilitated by government initiatives aimed at preventing the spread of avian diseases and lessen the utilization of antibiotics in the production of poultry. The growth is further attributed to better procurement and growing interest in molecular diagnostics and point-of-care testing solutions.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 10.0% |
The poultry diagnostics market is expected to thrive in Japan, owing to its emphasis on biosecurity and disease prevention in the poultry industry. Next generation sequencing and real-time PCR, which are advanced diagnostic technologies, are also gaining popularity in the country.
Rising focus of government agencies and private players on collaborations to invest in animal health research is further driving the growth of the animal health market.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 10.1% |
The higher surge of avian influenza and other poultry diseases across South Korea is driving the demand for poultry diagnostic solutions in country. The key growth factors are the government´s focus on proactive disease surveillance and the increasing poultry farming in the country. Additionally, improvements in diagnostic tools are speeding up disease detection and increasing its accuracy.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 10.0% |
| By Test Type | Market Share (2025) |
|---|---|
| ELISA Test | 52.3% |
ELISA Test the enzyme-linked immunosorbent assay (ELISA) test which is a commonly used diagnostic technique for poultry, enabling accurate and timely identification of infectious diseases that threaten poultry health and productivity.
Such testing is commonly used because of its high sensitivity, easiness, and ability to perform high throughputs of samples all at once. ELISA test is an important serology test which is used for the identification of specific antigens or antibodies related to major poultry diseases which is popularly used by poultry farms and veterinarians to achieve early diagnosis of disease and its management.
The poultry industry is highly susceptible to viral and bacterial outbreaks, and ELISA tests are essential components of disease surveillance programs for the poultry sector. They help identify diseases like avian influenza, Newcastle disease, and infectious bronchitis before they move through flocks.
The automation processing features make the ELISA tests provide consistent and reproducible results enabling poultry producers to quickly respond and control disease outbreaks.
The growing development of commercial poultry farming creates an increasing need for cost-effective and scalable diagnostic solutions. Routine health status monitoring, vaccination efficacy, and biosecurity measures are all facilitated by ELISA tests, resulting in better disease control in poultry farms.
Continuous advancements in immunodiagnostic technologies are enhancing the accuracy of ELISA tests, making the ELISA test further indispensable for highly accurate poultry diagnostic market.
| By Disease | Market Share (2025) |
|---|---|
| Avian Influenza | 47.8% |
Viruses of avian influenza have remained among the most severe threats in global poultry production, with high mortality rates, economic loss and trade bans. The rapid spread of very virulent pathogens, especially highly pathogenic avian influenza (HPAI) agglutinin low-pathogenic HPAI strains, results in the successive evolution of new strains which require rigorous screening and clearing of these pathogens in the laboratory.
Early detection is critical to stopping disease transmission and protecting commercial and backyard flocks for poultry producers, government agencies, and veterinary organizations.
Diagnostic tests such as ELISA and PCR test allow identification of strains of avian influenza and therefore public health and veterinary authorities are able to respond rapidly by culling affected flocks, vaccinating and quarantining birds. Evolving demand for avian influenza diagnostics is also driven by surveillance programs required by health authorities to allow timely containment with equally lower risk of human zoonosis.
Growth of global poultry trade drives regulatory agreement for disease-free certification increasing the demand for avian influenza diagnostic solutions in efficient manner. Such a development not only has the potential to improve disease control outcomes such as enhancing diagnostic assays and their sensitivity and rapidity, but also the ability to distinguish between vaccine-induced and natural infections.
Growing awareness towards poultry health and better practices in biosecurity will continue to fuel demand for gallus gallus detection, namely avian flu diagnostics, as contributing factors in the coming years.
The Poultry Diagnostics Market is driven by growing incidence of avian diseases, increasing need for poultry health monitoring systems and technological advancements in diagnostics.
Corporate interest centres upon creating more speedy, precise and affordable diagnostic methods for identifying infections in poultry caused by bacteria, virus as well as parasites. The top companies focus on molecular diagnostics, immunoassays, and point-of-care testing solutions that bolsters the disease prevention and management practices of the global poultry industry.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Agrobiotek Internacional | 18-22% |
| Idexx Laboratories Inc. | 14-18% |
| Boehringer Ingelheim GmbH | 12-16% |
| BioChek | 10-14% |
| Other Companies (combined) | 30-40% |
| Company Name | Key Offerings/Activities |
|---|---|
| Agrobiotek Internacional | In 2024, launched a next-generation molecular diagnostic kit for rapid avian influenza detection. |
| Idexx Laboratories Inc. | In 2025, expanded its ELISA-based poultry disease testing solutions for improved accuracy and efficiency. |
| Boehringer Ingelheim GmbH | In 2024, introduced a new line of PCR-based diagnostic tools for early-stage poultry disease detection. |
| BioChek | In 2025, enhanced its portfolio with advanced immunoassay-based diagnostic tests for global poultry farms. |
Key Company Insights
AgrobiotekInternacional (18-22%)
Agrobiotek leads the market with advanced molecular diagnostic solutions, focusing on rapid and high-precision poultry disease detection.
Idexx Laboratories Inc. (14-18%)
Idexx specializes in ELISA and PCR-based diagnostics, delivering efficient and scalable solutions for poultry disease screening.
BoehringerIngelheim GmbH (12-16%)
BoehringerIngelheim invests in early-stage disease diagnostics, ensuring effective poultry health monitoring and management.
BioChek (10-14%)
BioChek focuses on immunoassay-based diagnostics, providing innovative solutions for detecting avian diseases.
Other Key Players (30-40% Combined)
Several companies contribute to poultry disease diagnostics advancements, including:
The overall market size for the Poultry Diagnostics Market was USD 720.40 Million in 2025.
The Poultry Diagnostics Market is expected to reach USD 1,868.4 Million in 2035.
The demand is driven by increasing poultry production, rising prevalence of avian diseases, growing awareness of food safety and biosecurity measures, advancements in rapid diagnostic testing, and stringent government regulations on poultry health monitoring.
The top 5 countries driving market growth are the USA, UK, Europe, Japan and South Korea.
The ELISA (Enzyme-Linked Immunosorbent Assay) segment is expected to command a significant share over the assessment period.
Eyelid Scrub Market Analysis & Forecast by Product, Application and Region 2025 to 2035
Protein Diagnostics Market Share, Size and Forecast 2025 to 2035
CGRP Inhibitors Market Trends - Growth, Demand & Forecast 2025 to 2035
Indolent Systemic Mastocytosis treatment Market Insights: Size, Trends & Forecast 2025 to 2035
Intraoperative Fluorescence Imaging Market Report - Demand, Trends & Industry Forecast 2025 to 2035
Lung Cancer PCR Panel Market Trends, Growth, Demand & Forecast 2025 to 2035
Poultry Diagnostics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
